These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30307688)

  • 1. Age at diagnosis and the surgical management of small renal carcinomas: findings from a cross-sectional population-based study.
    White VM; Marco DJT; Bolton D; Papa N; Neale RE; Coory M; Davis ID; Wood S; Giles GG; Jordan SJ
    BJU Int; 2018 Nov; 122 Suppl 5():50-61. PubMed ID: 30307688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward greater adoption of minimally invasive and nephron-sparing surgical techniques for renal cell cancer in the United States.
    Banegas MP; Harlan LC; Mann B; Yabroff KR
    Urol Oncol; 2016 Oct; 34(10):433.e9-433.e17. PubMed ID: 27321355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary management of renal cell carcinoma (RCC) in Victoria: implications for longer term outcomes and costs.
    Ta AD; Bolton DM; Dimech MK; White V; Davis ID; Coory M; Millar J; Giles G
    BJU Int; 2013 Nov; 112 Suppl 2():36-43. PubMed ID: 24127675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting positive surgical margins in partial nephrectomy: A prospective multicentre observational study (the RECORd 2 project).
    Schiavina R; Mari A; Bianchi L; Amparore D; Antonelli A; Artibani W; Brunocilla E; Capitanio U; Fiori C; Di Maida F; Gontero P; Larcher A; Li Marzi V; Longo N; Marra G; Montanari E; Porpiglia F; Roscigno M; Simeone C; Siracusano S; Tellini R; Terrone C; Villari D; Ficarra V; Carini M; Minervini A;
    Eur J Surg Oncol; 2020 Jul; 46(7):1353-1359. PubMed ID: 32007380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
    Crépel M; Jeldres C; Sun M; Lughezzani G; Isbarn H; Alasker A; Capitanio U; Shariat SF; Arjane P; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Urology; 2010 Oct; 76(4):883-8. PubMed ID: 20932408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the hospital volume threshold to optimize inpatient complication rate after partial nephrectomy?
    Arora S; Keeley J; Pucheril D; Menon M; Rogers CG
    Urol Oncol; 2018 Jul; 36(7):339.e17-339.e23. PubMed ID: 29773492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of new-onset chronic kidney disease in patients managed surgically for T1a renal cell carcinoma: An Australian population-based analysis.
    Ahn T; Ellis RJ; White VM; Bolton DM; Coory MD; Davis ID; Francis RS; Giles GG; Gobe GC; Hawley CM; Johnson DW; Marco DJT; McStea M; Neale RE; Pascoe EM; Wood ST; Jordan SJ;
    J Surg Oncol; 2018 Jun; 117(7):1597-1610. PubMed ID: 29790163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour size, tumour complexity, and surgical approach are associated with nephrectomy type in small renal cortical tumours treated electively.
    Broughton GJ; Clark PE; Barocas DA; Cookson MS; Smith JA; Herrell SD; Chang SS
    BJU Int; 2012 Jun; 109(11):1607-13. PubMed ID: 21939493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the surgical management of stage 1 renal cell carcinoma: findings from a population-based study.
    White V; Marco DJT; Bolton D; Davis ID; Jefford M; Hill D; Prince HM; Millar JL; Winship IM; Coory M; Giles GG
    BJU Int; 2017 Nov; 120 Suppl 3():6-14. PubMed ID: 28452170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry.
    Venkatramani V; Koru-Sengul T; Miao F; Nahar B; Prakash NS; Swain S; Punnen S; Ritch C; Gonzalgo M; Parekh D
    Urol Oncol; 2018 Mar; 36(3):90.e9-90.e14. PubMed ID: 29254672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of surgical approach for the management of renal cell carcinoma: a population-based study from New South Wales.
    Patel MI; Strahan S; Bang A; Vass J; Smith DP
    ANZ J Surg; 2017 Nov; 87(11):E193-E198. PubMed ID: 27283936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease.
    Takagi T; Kondo T; Omae K; Iizuka J; Kobayashi H; Yoshida K; Hashimoto Y; Tanabe K
    Int Urol Nephrol; 2016 Sep; 48(9):1421-7. PubMed ID: 27193433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Adoption of Nephron-Sparing Surgery in Europe - A Trend Analysis in Two Referral Centers from Austria and Germany.
    Meyer C; Hansen J; Becker A; Schmid M; Pradel L; Strini K; Chromecki T; Jesche-Chromecki J; Fisch M; Zigeuner R; Chun FK
    Urol Int; 2016; 96(3):330-6. PubMed ID: 26699625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non-cancer-related survival benefit is associated with partial nephrectomy.
    Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
    Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005-2010: a population-based study from the national Swedish kidney cancer register.
    Thorstenson A; Bergman M; Scherman-Plogell AH; Hosseinnia S; Ljungberg B; Adolfsson J; Lundstam S
    Scand J Urol; 2014 Jun; 48(3):231-8. PubMed ID: 24666102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery.
    Butler BP; Novick AC; Miller DP; Campbell SA; Licht MR
    Urology; 1995 Jan; 45(1):34-40; discussion 40-1. PubMed ID: 7817478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clampless laparoendoscopic single-site partial nephrectomy for renal cancer with low PADUA score: technique and surgical outcomes.
    Springer C; Veneziano D; Wimpissinger F; Inferrera A; Fornara P; Greco F
    BJU Int; 2013 Jun; 111(7):1091-8. PubMed ID: 23360654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicted versus observed 30-day perioperative outcomes using the ACS NSQIP surgical risk calculator in patients undergoing partial nephrectomy for renal cell carcinoma.
    Blair BM; Lehman EB; Jafri SM; Kaag MG; Raman JD
    Int Urol Nephrol; 2018 Jul; 50(7):1249-1256. PubMed ID: 29868938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
    Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
    BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.